Company intelligence / Profile preview

Baiyunshan Hansen

Guangzhou, Guangdong, China

Ownership: Private
Employees: ~1300
Development stage: Other

Overview

Guangzhou Baiyunshan Pharmaceutical manufactures and markets over 300 pharmaceutical products, including generics such as sildenafil citrate (commercially successful as JinGe), memantine hydrochloride, dapoxetine, and novel cephalosporins. Key generic approvals achieved for sildenafil (first to pass generic conformity in China) and memantine, with additional clinical activity in anti-infectives.

Therapeutic areas: Men's HealthNeurologyInfectious Diseases
Modalities: Small moleculeBiologic
Industry: Biotech

Beyond the preview

Go deeper on Baiyunshan Hansen.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Baiyunshan Hansen.

Explore the full profile